New study aims to fix lack of diversity in cancer trials
NCT ID NCT05146297
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at ways to increase diversity in cancer clinical trials, focusing on breast, liver, and prostate cancers. Researchers worked with communities, doctors, and scientists in New York City to find better ways to include people of color and underserved groups. The goal was to change how trials are done so they reflect the real population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
-
Herbert Irving Comprehensive Cancer Care Center
New York, New York, 10032, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a new tracer light up hidden prostate cancer?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could deep breaths before surgery ward off Post-Op confusion?
- Could ionized gas help fight breast cancer after surgery?